Sarah Shigdar School of Medicine Deakin University Biography Publications Institution JoVE Articles Sarah Shigdar has not added a biography. If you are Sarah Shigdar and would like to personalize this page please email our Author Liaison for assistance. Publications Modelling of Mass Transport and Distribution of Aptamer in Blood-brain Barrier for Tumour Therapy and Cancer Treatment European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. Apr, 2022 | Pubmed ID: 35283304 Triple-negative Breast Cancer Brain Metastasis: An Update on Druggable Targets, Current Clinical Trials, and Future Treatment Options Drug Discovery Today. 05, 2022 | Pubmed ID: 35101641 Future of PD-1/PD-L1 Axis Modulation for the Treatment of Triple-negative Breast Cancer Pharmacological Research. 01, 2022 | Pubmed ID: 34861397 Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications Thereof Pharmaceutics. Dec, 2021 | Pubmed ID: 35056924 Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach International Journal of Molecular Sciences. Jun, 2021 | Pubmed ID: 34200484 Aptamers: Cutting Edge of Cancer Therapies Molecular Therapy : the Journal of the American Society of Gene Therapy. 08, 2021 | Pubmed ID: 34146729 Novel Detection of Nasty Bugs, Prevention Is Better Than Cure International Journal of Molecular Sciences. Dec, 2020 | Pubmed ID: 33375709 Author Correction: Aptamer-mediated Survivin RNAi Enables 5-fluorouracil to Eliminate Colorectal Cancer Stem Cells Scientific Reports. Dec, 2020 | Pubmed ID: 33311517 Non-Invasive Delivery of Therapeutics into the Brain: The Potential of Aptamers for Targeted Delivery Biomedicines. May, 2020 | Pubmed ID: 32422973 Strategies to Bioengineer Aptamer-driven Nanovehicles As Exceptional Molecular Tools for Targeted Therapeutics: A Review Journal of Controlled Release : Official Journal of the Controlled Release Society. 07, 2020 | Pubmed ID: 32380206 Mathematical Approaches in Estimating Aptamer-target Binding Affinity Analytical Biochemistry. 07, 2020 | Pubmed ID: 32315616 Antibodies, Nanobodies, or Aptamers-Which Is Best for Deciphering the Proteomes of Non-Model Species? International Journal of Molecular Sciences. Apr, 2020 | Pubmed ID: 32260091 Bifunctional Aptamer-Doxorubicin Conjugate Crosses the Blood-Brain Barrier and Selectively Delivers Its Payload to EpCAM-Positive Tumor Cells Nucleic Acid Therapeutics. 04, 2020 | Pubmed ID: 32027209 Anything You Can Do, I Can Do Better: Can Aptamers Replace Antibodies in Clinical Diagnostic Applications? Molecules (Basel, Switzerland). Nov, 2019 | Pubmed ID: 31801185 Aptamer-Based Diagnostics and Therapeutics Pharmaceuticals (Basel, Switzerland). Jan, 2019 | Pubmed ID: 30609700 Radiolabelled Aptamers for Theranostic Treatment of Cancer Pharmaceuticals (Basel, Switzerland). Dec, 2018 | Pubmed ID: 30586898 EpCAM Immunotherapy Versus Specific Targeted Delivery of Drugs Cancers. Jan, 2018 | Pubmed ID: 29329202 Aptamers As Potential Therapeutic Agents for Ovarian Cancer Biochimie. Feb, 2018 | Pubmed ID: 29224849 Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis Mini Reviews in Medicinal Chemistry. 2018 | Pubmed ID: 27145854 Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications International Journal of Molecular Sciences. Nov, 2017 | Pubmed ID: 29189740 Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures Molecules (Basel, Switzerland). Nov, 2017 | Pubmed ID: 29186905 Transforming Doxorubicin into a Cancer Stem Cell Killer Via EpCAM Aptamer-mediated Delivery Theranostics. 2017 | Pubmed ID: 29158811 Aptamer-mediated Survivin RNAi Enables 5-fluorouracil to Eliminate Colorectal Cancer Stem Cells Scientific Reports. 07, 2017 | Pubmed ID: 28724889 What Potential Do Aptamers Hold in Therapeutic Delivery? Therapeutic Delivery. 02, 2017 | Pubmed ID: 28088878 Development of a Bifunctional Aptamer Targeting the Transferrin Receptor and Epithelial Cell Adhesion Molecule (EpCAM) for the Treatment of Brain Cancer Metastases ACS Chemical Neuroscience. 04, 2017 | Pubmed ID: 28010059 Challenges and Opportunities for SiRNA-based Cancer Treatment Cancer Letters. 02, 2017 | Pubmed ID: 27045474 Truncation and Mutation of a Transferrin Receptor Aptamer Enhances Binding Affinity Nucleic Acid Therapeutics. 12, 2016 | Pubmed ID: 27500826 The Application of Aptamers for Immunohistochemistry Nucleic Acid Therapeutics. 06, 2016 | Pubmed ID: 26862683 Application of Aptamers in Histopathology Methods in Molecular Biology (Clifton, N.J.). 2016 | Pubmed ID: 26552827 The Control of Epidermal Growth Factor Grafted on Mesoporous Silica Nanoparticles for Targeted Delivery Journal of Materials Chemistry. B. Aug, 2015 | Pubmed ID: 32262664 EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model Theranostics. 2015 | Pubmed ID: 26681989 Cancer Stem Cell Targeted Therapy: Progress Amid Controversies Oncotarget. Dec, 2015 | Pubmed ID: 26496035 Overcoming Acquired Drug Resistance in Colorectal Cancer Cells by Targeted Delivery of 5-FU with EGF Grafted Hollow Mesoporous Silica Nanoparticles Nanoscale. Sep, 2015 | Pubmed ID: 26242620 Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors Theranostics. 2015 | Pubmed ID: 26199647 Fabrication of High Specificity Hollow Mesoporous Silica Nanoparticles Assisted by Eudragit for Targeted Drug Delivery Journal of Colloid and Interface Science. May, 2015 | Pubmed ID: 25617610 Nucleic Acid Aptamer-guided Cancer Therapeutics and Diagnostics: the Next Generation of Cancer Medicine Theranostics. 2015 | Pubmed ID: 25553096 Improved Efficacy and Reduced Toxicity of Doxorubicin Encapsulated in Sulfatide-containing Nanoliposome in a Glioma Model PloS One. 2014 | Pubmed ID: 25072631 Epithelial Cell Adhesion Molecule Aptamer Functionalized PLGA-lecithin-curcumin-PEG Nanoparticles for Targeted Drug Delivery to Human Colorectal Adenocarcinoma Cells International Journal of Nanomedicine. 2014 | Pubmed ID: 24591829 Cancer Stem Cells: A Contentious Hypothesis Now Moving Forward Cancer Letters. Mar, 2014 | Pubmed ID: 24333726 Inflammation and Cancer Stem Cells Cancer Letters. Apr, 2014 | Pubmed ID: 23941828 Inhibition of A/Human/Hubei/3/2005 (H3N2) Influenza Virus Infection by Silver Nanoparticles in Vitro and in Vivo International Journal of Nanomedicine. 2013 | Pubmed ID: 24204140 Aptamers As Theranostic Agents: Modifications, Serum Stability and Functionalisation Sensors (Basel, Switzerland). Oct, 2013 | Pubmed ID: 24152925 The Use of Sensitive Chemical Antibodies for Diagnosis: Detection of Low Levels of EpCAM in Breast Cancer PloS One. 2013 | Pubmed ID: 23460885 RNA Aptamers Targeting Cancer Stem Cell Marker CD133 Cancer Letters. Mar, 2013 | Pubmed ID: 23196060 Enhanced Antitumor Efficacy and Reduced Systemic Toxicity of Sulfatide-containing Nanoliposomal Doxorubicin in a Xenograft Model of Colorectal Cancer PloS One. 2012 | Pubmed ID: 23145140 Cancer Stem Cell Targeting: the Next Generation of Cancer Therapy and Molecular Imaging Therapeutic Delivery. Feb, 2012 | Pubmed ID: 22834199 Clinical Applications of Aptamers and Nucleic Acid Therapeutics in Haematological Malignancies British Journal of Haematology. Oct, 2011 | Pubmed ID: 21810089 RNA Aptamer Against a Cancer Stem Cell Marker Epithelial Cell Adhesion Molecule Cancer Science. May, 2011 | Pubmed ID: 21281402 Cytochemical Characterisation of the Leucocytes and Thrombocytes from Murray Cod (Maccullochella Peelii Peelii, Mitchell) Fish & Shellfish Immunology. May, 2009 | Pubmed ID: 19332132 Functional Interaction Between Mutations in the Granulocyte Colony-stimulating Factor Receptor in Severe Congenital Neutropenia British Journal of Haematology. Aug, 2008 | Pubmed ID: 18513286 A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer Maryam Nakhjavani1,2, Breanna Giles1,2, Mia Strom1,2, Chris Vi1,2, Sahara Attenborough1,2, Sarah Shigdar1,2 1School of Medicine, Deakin University, 2Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University JoVE 64304 Krebsforschung
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer Maryam Nakhjavani1,2, Breanna Giles1,2, Mia Strom1,2, Chris Vi1,2, Sahara Attenborough1,2, Sarah Shigdar1,2 1School of Medicine, Deakin University, 2Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University JoVE 64304 Krebsforschung